stockrow
Friday 6 November 2026
Export COR’s income statement to Excel — free account
Cencora, Inc.
COR Healthcare Medical Distribution
Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.
- Revenue
- +5.52%
- EPS
- +258.4%
- Free cash flow
- −7.81%
- Total debt
- +47.1%
Quarter to September 2026, against a year earlier
339.76
14.24
−4.02%
Follow COR
Alert me
Cencora, Inc. (COR) EPS (diluted)
Cencora, Inc.'s EPS (diluted) for fiscal 2026 was $18.04, up 126.6% from $7.96 in fiscal 2025. Over the past ten years it has ranged from −$16.65 (fiscal 2020) to $18.04 (fiscal 2026) — the current reading is the highest in ten years. Cencora, Inc. ranks 2nd of 11 Medical Distribution companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2026 | $18.04 | 126.64% |
| FY2025 | $7.96 | 5.71% |
| FY2024 | $7.53 | (11.72%) |
| FY2023 | $8.53 | 6.09% |
| FY2022 | $8.04 | 8.80% |
| FY2021 | $7.39 | — |
| FY2020 | −$16.65 | — |
| FY2019 | $4.04 | (46.35%) |
| FY2018 | $7.53 | 359.15% |
| FY2017 | $1.64 | (74.05%) |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Sep 2026 | $2.76 | (29.96%) |
| Jun 2026 | $3.94 | (53.10%) |
| Mar 2026 | $8.40 | 192.68% |
| Dec 2025 | $2.87 | — |
| 43 more quarters | Free account |
Against its own ten years
Low −$16.65
High $18.04
Ten-year median
$7.46
Current reading's percentile
100
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| MCK McKesson Corporation compare | $38.89 |
| COR Cencora, Inc. | $17.97 |
| CAH Cardinal Health, Inc. compare | $7.73 |
| HSIC Henry Schein, Inc. compare | $3.71 |
| AHG Akso Health Group Sponsored ADR compare | −$0.55 |
| COSM Cosmos Health Inc. compare | −$0.64 |
| FOCL FocalTherics compare | −$1.03 |
| YI 111, Inc. Sponsored ADR compare | −$1.40 |
| ACH Accendra Health, Inc. compare | −$3.91 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on COR
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement